Tuesday, November 24, 2009, 6:47pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Smith & Nephew plc (SNN)

At 5:01AM SGT: 48.03 USD   0.00 (0.00%)  
 MORE ON SNN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 SMITH&NEPHEW PLC NEW (NYSE:SNN) Delayed quote dataEdit
Last Trade:48.03 USD
Trade Time:5:01AM SGT
Change: 0.00 (0.00%)
Prev Close:48.03
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:44.67
Day's Range:N/A - N/A
52wk Range:30.01 - 48.95
Volume:0
Avg Vol (3m):77,369.2
Market Cap:8.48B
P/E (ttm):18.47
EPS (ttm):2.60
Div & Yield:0.68 (1.41%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add SNN to Portfolio   Download Data

 HEADLINES 
•[$$] A Time to Fight, a Time to Heal
at Barrons.com (Sat, Nov 21)
•Smith & Nephew wins Department of Defense contract
at bizjournals.com (Sat, Nov 21)
•Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries
PR Newswire (Fri, Nov 20)
•Smith & Nephew Supports New CPT Code for Multi-Layer Compression Bandaging Systems
PR Newswire (Thu, Nov 19)
•Smith & Nephew Endoscopy Announces Availability of TRUCLEAR(TM) Hysteroscopic Morcellator at the AAGL Annual Meeting
PR Newswire (Tue, Nov 17)
•Zimmer to Sell Notes
Zacks.com (Fri, Nov 13)
•Stryker Strikes Acquisition Deals
Zacks.com (Fri, Nov 13)
•Wright Receives FDA Approval
Zacks.com (Wed, Nov 11)
•Smith & Nephew to buy Nucryst assets for $21 mln
at MarketWatch (Wed, Nov 11)
•Centers for Medicare & Medicaid Services Retain Single NPWT Code
PR Newswire (Mon, Nov 9)
•Q3 2009 Smith & Nephew Earnings Release - 02:00 am ET
CCBN (Fri, Nov 6)
•Smith & Nephew Earnings Call scheduled for 3:30 am ET today
CCBN (Fri, Nov 6)
•Smith & Nephew net profit jumps 73%, revenue slips
at MarketWatch (Fri, Nov 6)
More Headlines for SNN...
 ANALYST 
EPS Est (next year) (Dec-09) :3.01
EPS Est (in 2 years) (Dec-10) :3.27
Avg Rec (current)*:3.0
PEG Ratio:1.44
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, marketing, and sale of medical devices worldwide. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices